US 10611998
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted A61KA61K35/12A61P
Quick answer
US patent 10611998 (Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury) held by The Regents of the University of California expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K35/12, A61P, A61P25/00, A61P25/28